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ABSTRACT
Background/aims To assess the impact of impaired
cognition on visual outcomes 1 year following cataract
surgery in a cohort of older people.
Methods Participants aged 75 years or more with
bilateral cataract and scheduled for cataract surgery
were recruited consecutively. Cognition was assessed
using the revised Addenbrooke’s cognitive examination
(ACE-R). Participants were divided into two groups:
normal (ACE-R ≥88) and impaired cognition (ACE-R
<88). Visual quality of life (VQOL) and logarithm of
minimum angle of resolution visual acuity (VA) were
assessed at baseline and 1 year following cataract
surgery.
Results Of 112 participants, 48 (43%) had normal
cognition and 64 (57%) had impaired cognition. One
year following cataract surgery participants in both
groups had significant improvements in VQOL and VA.
Visual outcomes at 1 year were significantly better in
participants with normal cognition than in those with
impaired cognition (95% CIs for difference 0.4–7.0 and
0.02–0.1, for VQOL and VA, respectively). Regression
analyses correcting for potential confounders showed a
relationship between baseline cognition and VA at
1 year (R2=0.30, p=0.001) and a possible relationship
between baseline cognition and VQOL at 1 year
(R2=0.41, p=0.01, this became insignificant after
removal of outliers).
Conclusions Patients with impaired cognition benefit
from cataract surgery, but not to the same extent as
patients with normal cognition.
INTRODUCTION
Cataract and cognitive impairment are both
age-related health problems which rise in preva-
lence as populations age. Cataract is the leading
diagnosis for ambulatory (outpatient) surgery visits
in the USA1 and cataract surgery is the most
common elective surgical procedure carried out in
the UK National Health Service.2 The prevalence
rate of dementia in people aged 75–79 years is
≈6% and double that in the 80–84 age group.3
The prevalence of mild cognitive impairment
(MCI) is reported as up to 42% in older popula-
tions.4 Therefore, in cataract clinics, where many of
the patients attending are in older age groups, one
would expect to see large numbers of people with
dementia and MCI. For example, a cataract
surgeon operating on 20 patients a week would be
expected to operate on ≈50 patients with dementia
each year.i It is, therefore, important to understand
the implications of cognitive impairment on visual
acuity (VA) and visual quality of life (VQOL) out-
comes for people undergoing cataract surgery.
Older age is known to limit improvements from
cataract surgery, even when other ocular comorbid-
ities have been taken into account.5 6 We have pre-
viously hypothesised that this may, in part, be due
to cerebral ageing and, therefore, postoperative
outcomes may be further limited by the additional
presence cognitive impairment.7 The aim of this
study, therefore, was to assess whether cognitive
function influenced visual outcomes from cataract
surgery in a cohort of older people.
METHODS
This research adhered to the tenets of the declar-
ation of Helsinki. Ethics committee approval was
obtained from the County Durham and Tees Valley
research ethics committee.
Participants
Participants were recruited consecutively from pre-
assessment cataract clinics at a single study centre
in the North East of England between March 2011
and August 2012. Participants were eligible for
inclusion if they were aged 75 years or more, had
bilateral cataract, were scheduled for first eye cata-
ract surgery, had no ocular comorbidity, had no
visually significant age-related macular changes
(assessed using a 78D lens at the slit lamp and com-
pared with standardised photographs based on the
guidelines laid out in8), were fluent in the English
language, had a mini-mental state examination
(MMSE) score >12 and had capacity to consent to
participation. Informed consent was obtained from
all participants.
Selection of a patient reported outcome measure
Careful consideration was given to the selection of
a suitable patient-reported outcome measure
(PROM) for the current study. Guidance was taken
from the Cochrane Health Related Quality of Life
methods group9 and previous reviews of the use of
PROMs in ophthalmology.10 11 The National Eye
Institute 25 item Visual Functioning Questionnaire
iAssumes 20% of patients from each of the age groups:
60–64, 65–69, 70–74, 75–79 and 80–84 years with %
prevalence rates for dementia of 0.9, 1.5, 3.6, 6.0 and
12.2, respectively.3
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(VFQ-25)12 was selected for its favourable psychometric proper-
ties, its short administration time (10 min) and the breadth of
concepts covered (including those about visual symptoms and
functioning as well as the mental health and social influences of
vision). The VFQ-25 has also been used widely in previously
published literature and in a variety of different eye diseases (it
is not specific to cataract). The VFQ-25 is scored from 0 (worst
VQOL) to 100 (best VQOL).
Assessment measures
Participants were assessed preoperatively and at 1 year following
first surgery. An interim appointment was also made at
3 months postoperatively if having single eye surgery or
2 months after second eye surgery if having sequential eye sur-
geries. Baseline assessment included demographic and medical
questionnaire, clinical history from the participant and where
available an informant detailing any cognitive symptoms,
grading of lens opacities with the lens opacity classification
system III (LOCSIII)13 and age-related macular disease (AMD)
grading based on the guidelines of the international classifica-
tion and grading system.8 At baseline, interim appointment and
1 year postoperatively the following assessments were per-
formed: logarithm of minimum angle of resolution (logMAR)
VA, Addenbrooke’s Cognitive Examination (ACE-R; which
includes the MMSE),14 National Eye Institute VFQ-2512 and 15
item Geriatric Depression Scale (GDS-15).15 VA was defined as
best logMAR VA in the better eye, corrected with up to date
refraction and/or pinhole. The ACE-R is scored from 0 (worst
cognition) to 100 (best cognition). The LOCSIII system for
grading cataract scores four different aspects of lens opacity
(nuclear colour, nuclear opalescence, cortical and posterior sub-
capsular) from 1 (no opacity) to 5 or 6 (most opacity). As a
summary for cataract grade, we took the highest of these four
scores for each eye and then used the grade from the eye with
the least cataract (lower grade). AMD was graded as 0 (no
changes), 1 (insignificant changes) or 2 (mild changes), and the
grade from the least affected eye was used for analysis.
Participants were classified according to the predefined
cut-offs on the ACE-R into normal cognition (ACE-R ≥88) and
impaired cognition (ACE-R <88). This cut-off has been
reported to have a sensitivity of 0.94 and a specificity of 0.89
for detecting dementia.14 To aid clinical transferability of the
results participants were also grouped according to whether
they met clinical criteria for dementia or MCI. History taking
and cognitive assessment from the participant and, where pos-
sible, an informant was taken by a clinician ( JMJ). The diagnos-
tic criteria for dementia from the Diagnostic and Statistical
Manual V.4 were used to determine whether participants met
the criteria for dementia16 and Petersen criteria were used to
determine whether participants had MCI.17 Any dementia/MCI
cases and borderline cases were discussed with an expert clin-
ician ( J-PT) to confirm or refute the diagnosis. To mimic clinical
practice, no absolute cut-off values were used to define either
dementia or MCI, but a whole clinical picture taking into
account: the participant’s level of functioning, ACE-R score,
level of education and any report from participant, informant
or another clinician that cognitive performance had changed
from a previous level.
Statistical analysis
Statistical Package for Social Scientists (SPSS) V.17 was used for
all the statistical analysis. p Values <0.05 were considered sig-
nificant. Variables of interest were compared between cognitive
groups and between those completing and not completing
1-year follow-up. Variables were compared using Pearson χ2 test
(dichotomous variables), independent t test (normally distribu-
ted variables) or Mann-Whitney U test (non-normally distribu-
ted variables).
Comparisons of visual measures (VQOL or VA) at baseline
versus 1 year were made with paired t tests. Where significant dif-
ferences were found, paired t tests were used to compare
3-month postop measures to baseline and 1-year measures.
Between-group comparisons were made with independent t tests.
Analysis of covariance (ANCOVA) was used to compare
outcome (VQOL or VA) at 1 year between cognitive groups
while controlling for that measure at baseline. This approach
was chosen as it generally gives greater statistical power than
using the change from baseline or the percentage change as the
outcome variable. The assumption of homogeneity of variance
was checked using variance ratios compared against critical
values for Hatley’s Fmax.
18
Linear regression models were used to assess the relationship
between baseline cognition (predictor variable) and visual out-
comes at 1 year (outcome variable) while correcting for potential
co-predictors. The visual outcomes VQOL and VA were analysed
separately and corresponding measures at baseline were entered
as co-predictors. Other potential predictors were selected a priori
if known to affect VA, VQOL and/or cognition as: age, gender,
education, AMD grade, cataract grade, GDS-15 score and unilat-
eral/sequential surgery. A backwards stepwise regression model
was used to eliminate statistically redundant co-predictors.
Multicollinearity and auto-correlation were checked for using tol-
erance statistics and Durbin–Watson test statistics, respectively. A
normal probability plot of standardised residuals was used to
ensure they were normally distributed. Individual cases with stan-
dardised residuals outside the range ±3.0 were identified and the
regression model repeated excluding them.
The main analysis was based on a complete case analysis. To
ensure losses to follow-up did not affect significantly the results,
we also performed last outcome carried forward analyses where
appropriate.
RESULTS
Figure 1 shows a summary of recruitment and follow-up
numbers. A total of 112 participants were included in the base-
line analysis, 99 (88%) at the interim appointment and
91 (81%) at 1 year. Of the 112 participants at baseline, 64
(57%) had an ACE-R score <88 and were classified as having
impaired cognition. For all participants, baseline mean ACE-R
score (SD) was 83.7 (10.3). Of the three participants who died
during the study follow-up (figure 1) all were in the impaired
cognition group. There were significantly more participants
completing follow-up in the normal cognition group (96%)
than in the impaired cognition group (70%; Pearson χ2,
p=0.001). Table 1 shows the baseline characteristics for partici-
pants and a comparison between cognitive groups.
Of the 91 participants completing follow-up, 68 (74.7%) had
undergone bilateral sequential surgeries. There were no signifi-
cant differences in the number of participants who had under-
gone bilateral surgeries between the impaired cognition and
normal cognition groups (Pearson χ2, p=0.76).
A total of nine (8.0%) participants met a diagnosis of demen-
tia and 23 (20.5%) had MCI. Of these 32 participants with
either dementia or MCI, only three (9%) had previously been
seen in a memory clinic.
Table 2 compares visual measures (VA and VQOL) between
baseline and 1 year for the two cognitive groups. It also shows
comparisons of VA and VQOL between cognitive groups.
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Significant differences between the two cognitive groups for
VQOL (F=4.8, p=0.03) and VA (F=4.9, p=0.03) remained
robust after the application of an ANCOVA with VQOL/VA at
1 year the dependent variable and VQOL/VA at baseline a cov-
ariate. Whole group analysis showed that participants (n=91)
had improved VQOL at 1 year compared with baseline (mean
difference 13.5, 95% CI 11.0 to 15.9) and the same was true
for VA (0.12, 0.10 to 0.15). Interim analysis showed that VQOL
improved at interim appointment compared with baseline
(mean difference 11.9, 95% CI 9.6 to 14.2) and further
improved at 1 year compared with interim (1.5, 0.0 to 3.1). VA
also improved at interim appointment compared with baseline
(mean difference 0.12, 95% CI 0.09 to 0.14) but not further at
1 year compared with interim (0.00, −0.01 to 0.02).
When missing data at 1 year follow-up was imputed using a last
outcome carried forward approach, paired t tests comparing 1-year
follow-up with baseline for the 48 participants with normal cogni-
tion showed improved VQOL (mean difference 13.8, 95% CI 10.5
to 17.0) and improved VA (0.12, 0.09 to 0.16). Similarly, for the
64 participants with impaired cognition, comparisons between
1 year and baseline showed improvements in VQOL (mean differ-
ence 9.5, 95% CI 6.4 to 12.6) and VA (0.11, 0.07 to 0.15).
When participants were grouped according to the clinical
diagnosis, those with dementia or MCI saw significant improve-
ments in VQOL (mean difference 10.2, 95% CI 2.8 to 17.5)
and VA (0.1, 0.03 to 0.16). When compared with those not
reaching a diagnosis of dementia or MCI, the dementia/MCI
group had significantly poorer VQOL at 1 year (mean difference
5.2, 95% CI 1.4 to 9.0) and significantly poorer VA at 1 year
(0.07, 0.02 to 0.12).
Table 3 shows the results of the regression analyses. For each
visual outcome, a summary of the initial model (including all
Figure 1 Recruitment and Retention
flow- chart.
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predictors) and the final model (after backwards stepwise regres-
sion removed statistically redundant predictors) is shown.
Cognition was a significant predictor of VQOL in the model but
this became insignificant following the removal of outliers with
absolute standardised residuals >3. Therefore, there remains
uncertainty as to whether cognition was a significant predictor
of VQOL. Cognition was, however, a significant predictor of
VA, both in the initial and final regression models, with higher
ACE-R score (better cognition) predictive of lower logMAR VA
score (better vision; table 3).
DISCUSSION
In this group of older people attending for cataract surgery
from the community, 64 (57%) had ACE-R scores <88 and 32
(29%) met the diagnostic criteria for dementia or MCI, suggest-
ing that there are significant levels of cognitive impairment in a
typical UK-based cataract clinic. Measures of VQOL and VA
improved significantly for participants across all levels of cogni-
tion. However, poor cognition adversely affected VA outcomes
and had a possible impact on VQOL outcomes.
We noted some significant differences in demographics
between the two cognitive groups (see table 1), with lower
levels of education in the impaired cognition group. This is not
unexpected, as education and with it, poorer socioeconomic
status is a known risk factor for cognitive impairment.19
Furthermore, those with lower educational level may struggle
with certain aspects of cognitive assessment. We also saw lower
mood in the cognitively impaired group. Poor mood may impair
test performance on cognitive tasks due to poor concentration
and motivation; depression is known to be associated with
dementia and may be an independent risk factor for developing
dementia.20 There was a difference in baseline VA between the
two cognitive groups (table 1) but no differences in cataract
density or macular changes. This supports the idea of a more
direct relationship between vision and cognition, not simply as a
result of higher levels of recognisable ocular comorbidity in
those with lower cognition.
For participants in both groups, we saw a significant benefit
following cataract surgery in terms of VQOL and VA. The mean
improvements in VQOL of 12.4 (impaired cognition group) and
14.4 (normal cognition group) (see table 2) are clinically signifi-
cant and similar to improvements reported previously following
cataract surgery.21 22 The improvement in VA of 0.12 is equiva-
lent to six letters (or just over one line) on the logMAR VA
chart; this was significantly less than reported improvements in
visual acuities seen in a recent UK audit,23 but this looked at
improved vision for individual eyes (monocular vision) and not
for patients (binocular vision) as we have done here. These
results highlight the use of cataract surgery for patients in both
normal and cognitively impaired populations.
Despite both groups seeing improvements in visual outcomes,
there were significant differences between the groups in terms
of VQOL and VA outcomes at 1 year (table 2). These differ-
ences remained when using an ANCOVA to correct for baseline
VA/VQOL measures. Similar results were also seen when partici-
pants were grouped according to diagnosis (MCI or dementia)
as opposed to cognitive score. While differences between
impaired cognition and normal cognition groups in terms of VA
and VQOL at 1 year were statistically significant, they were
somewhat small and may not be clinically significant (table 2).
As well as considering participants divided into cognitive
groups, we have examined cognition as a continuous variable in
Table 1 Demographics of participants at baseline comparing
cognitive groups
Cognitive group
Normal
(n=48)
Impaired
(n=64) p Value*
Age, mean (SD), years 80.0 (3.8) 81.2 (3.9) 0.11
Gender, n (%) men 20 (42) 30 (47) 0.58
Years full-time education,
median (IQR)
11 (10–13) 10 (9–11) <0.001
Depression score, GDS-15,
median (IQR)
2 (1–3.75) 3 (1–5) 0.03
Cognition score, ACE-R,
mean (SD)
92.3 (2.9) 77.2 (9.0) <0.001
VFQ-25, mean (SD) 79.9 (12.5) 77.3 (14.9) 0.34
logMAR VA, mean (SD) 0.13 (0.09) 0.21 (0.17) 0.002
AMD grade, median (IQR) 0 (0–1) 0 (0–0) 0.45
Cataract grade, mean (SD) 3.48 (0.54) 3.60 (0.69) 0.33
*p Value refers to independent t test, Pearson-χ2 or Mann–Whitney U as appropriate.
Note, that higher GDS-15 scores represent poorer mood, higher ACE-R scores
represent higher cognition, higher VFQ-25 scores represent better functioning, higher
logMAR scores represent worse VA, higher AMD grade indicates more macular
changes and higher cataract grade represents more dense cataract.
ACE-R, Addenbrooke’s Cognitive Examination; AMD, age-related macular
degeneration; GDS-15, 15 item Geriatric Depression Score; logMAR, logarithm of
minimum angle of resolution; VA, visual acuity; VFQ-25,25-item Visual Functioning
Questionnaire.
Table 2 Visual outcomes at baseline and 1 year for the two cognitive groups
Baseline mean (SD) 1 year mean (SD)
95% CI for difference between
baseline and 1 year* p Value*
Outcome: visual quality of life
Normal cognition (n=46) 79.3 (12.4) 93.7 (5.5) 11.2 to 17.7 <0.001
Impaired cognition (n=45) 77.6 (13.9) 90.0 (9.6) 8.6 to 16.3 <0.001
95% CI for difference between cognitive groups† −3.8 to 7.8 0.4 to 7.0
p Value† 0.5 0.03
Outcome: best corrected visual acuity
Normal cognition (n=46) 0.13 (0.09) 0.00 (0.09) 0.09 to 0.16 <0.001
Impaired cognition (n=45) 0.18 (0.14) 0.06 (0.11) 0.08 to 0.16 <0.001
95% CI for difference between cognitive groups† 0.00 to 0.10 0.02 to 0.10
p Value† 0.05 0.007
*From paired t tests.
†From independent t tests.
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the regression analysis. While the dichotomisation of ACE-R
scores is useful for clinical and statistical interpretation, studying
cognition as a continuous variable affords greater statistical
power.24 Regression analysis allows correction for potential con-
founders (eg, education/comorbid depression) and these ana-
lyses (table 3) confirmed a significant association between
cognition and VA. The relationship between cognition and
VQOL was less significant and not robust to removal of outliers.
The association between cognition and vision cannot easily be
explained by macular changes or denser cataract in those with
cognitive impairment as there were no differences between cog-
nitive groups in cataract or AMD measures (table 1), and they
were corrected for in the regression model (table 3). Other pos-
sible explanations include higher levels of unrecognised path-
ology in those with lower cognition (eg, retinal or optic nerve
pathology not identifiable by slit lamp biomicroscopy)25 26;
a common underlying degenerative aetiology for vision and cog-
nitive impairment7 or an impact of cognition on attention, deci-
sion making and judgement skills required to read down a letter
chart.27 These factors could also account for the differences in
VA seen between cognitive groups at baseline (see table 1).
In this sample of older people, 57% of participants fell below
the ACE-R cut-off of 88 points, a significantly higher percentage
than those meeting a diagnosis of dementia or MCI (29%). It
has been suggested that an ACE-R cut-off of <88 may be too
stringent for day-to-day clinical practice and hence overestimate
dementia,28 and this study would support this assertion. Our
cohort was older than those used to describe these cognitive
cut-offs and there is a lack of normative data on the ACE-R for
people aged over 75 years.14 Our data does, however, suggest
that there are significant levels of undiagnosed dementia within
the eye clinic and thus ophthalmologists may have a role in initi-
ating onward referrals.
Our recruitment and attrition rates (figure 1) are in line with
other studies in similar populations.29 30 However, we saw sig-
nificantly higher levels of attrition in the impaired cognition
group and this may limit the generalisability of the results. To
address the possibility that losses to follow-up were not com-
pletely at random (people with poor cognition or poor vision
may find it harder to complete the study follow-up), we used a
last outcome carried forward analysis which did not alter our
conclusions. However, in this study, we have not considered
those with severe cognitive impairment and thus the conclusions
cannot necessarily be extrapolated to this patient group.
This research emphasises the use of cataract surgery in those
with both normal and impaired cognition, with both groups
experiencing significant improvements in visual outcomes.
Cognitive impairment may, however, limit visual improvements
following cataract surgery. Ophthalmologists helping patients
to make decisions about whether to undergo cataract surgery
need to take into account cognitive impairment, in the same
way that older age and ocular comorbidities are considered as
factors that may limit visual outcomes from cataract surgery.
Meanwhile, further research is needed to understand the rela-
tionship between vision and cognition we have noted. It could
be due to poor attention and concentration during VA testing
in those with reduced cognition, as opposed to truly poorer
vision suggesting that different approaches to accurately assess
VA in patients with suspected cognitive impairment are
needed.
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